{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:25:36Z","timestamp":1793838336683,"version":"4.6.1"},"reference-count":124,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Alzheimer\u2019s disease (AD) is a complex and progressive brain disorder marked by\nmemory loss, cognitive decline, and behavioral changes. One of its defining features is the build-up\nof amyloid plaques, clumps of &amp;#946;-amyloid (A&amp;#946;) peptides, in the brain, along with the formation of\nneurofibrillary tangles. These A&amp;#946; peptides are generated when the amyloid precursor protein (APP)\nis cleaved by enzymes, with &amp;#946;-secretase (BACE1) playing a key role in the first step of this process.\nBecause BACE1 starts the cascade that leads to harmful A&amp;#946; build-up, it has become an important\ntarget in the search for effective Alzheimer\u2019s treatments. As A&amp;#946; accumulates in neurons, it disrupts\ncommunication between brain cells and triggers oxidative stress, which worsens damage and accelerates\ndisease progression. This is often exacerbated by imbalances in metal ions, such as copper\nand iron. While tacrine, an early acetylcholinesterase inhibitor, has shown benefits in managing AD\nsymptoms, its limitations have led researchers to explore improved versions. One promising direction\nis the development of tacrine-based hybrid molecules. By combining tacrine with other chemical\ngroups that have anti-&amp;#946;-amyloid (A&amp;#946;) effects, antioxidant properties, and metal-chelating properties,\nscientists aim to create compounds that target multiple aspects of the disease simultaneously.\nThis review examines the emerging potential of tacrine hybrids, particularly their capacity to inhibit\nBACE1 and prevent A&amp;#946; aggregation, providing new hope for more effective and disease-modifying\ntherapies for Alzheimer\u2019s disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575422492251116190843","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:11:21Z","timestamp":1767957081000},"page":"253-268","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5243-1476","authenticated-orcid":true,"given":"Angamuthu","family":"Prabakaran","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Chennai, 600 097, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-1478","authenticated-orcid":true,"given":"Amuthulakshmi","family":"Sivaperuman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Chennai, 600 097, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramalakshmi","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Chennai, 600 097, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-3154","authenticated-orcid":true,"given":"Nalini Calambur","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, C.L. Baid Metha College of Pharmacy, Chennai. 600 097, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-4452","authenticated-orcid":true,"given":"Viswas Raja","family":"Solomon","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"Qiu C","year":"2009","unstructured":"Qiu C; Kivipelto M; von Strauss E; Epidemiology of Alzheimer's disease: Occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci  2009,11(2),111-128","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=2","first-page":"149","volume":"70","author":"Dumurgier J.","year":"2020","unstructured":"Dumurgier J.; Sabia S.; [Epidemiology of Alzheimer\u2019s disease: Latest trends]. Rev Prat  2020,70(2),149-151","journal-title":"Rev Prat"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/jgs.16027","volume":"67","author":"Gao S.","year":"2019","unstructured":"Gao S.; Burney H.N.; Callahan C.M.; Purnell C.E.; Hendrie H.C.; Incidence of dementia and Alzheimer disease over time: A meta\u2010analysis. J Am Geriatr Soc  2019,67(7),1361-1369","journal-title":"J Am Geriatr Soc"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9171424","volume":"2019","author":"Trevisan K.","year":"2019","unstructured":"Trevisan K.; Cristina-Pereira R.; Silva-Amaral D.; Aversi-Ferreira T.A.; Theories of aging and the prevalence of Alzheimer\u2019s disease. BioMed Res Int  2019,2019,1-9","journal-title":"BioMed Res Int"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Breijyeh Z.","year":"2020","unstructured":"Breijyeh Z.; Karaman R.; Comprehensive review on Alzheimer\u2019s disease: Causes and treatment. Molecules  2020,25(24),5789","journal-title":"Molecules"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","volume":"29","author":"Fish P.V.","year":"2019","unstructured":"Fish P.V.; Steadman D.; Bayle E.D.; Whiting P.; New approaches for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett  2019,29(2),125-133","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jalz.2016.08.007","volume":"13","author":"Leyhe T.","year":"2017","unstructured":"Leyhe T.; Reynolds C.F.; Melcher T.; Linnemann C.; Kl\u00f6ppel S.; Blennow K.; Zetterberg H.; Dubois B.; Lista S.; Hampel H.; A common challenge in older adults: Classification, overlap, and therapy of depression and dementia. Alzheimers Dement  2017,13(1),59-71","journal-title":"Alzheimers Dement"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","year":"2019","unstructured":"2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement Alzheimer\u2019s Association 2019,15(3),321-387","journal-title":"Alzheimers Dement"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"Boyle P.A.","year":"2019","unstructured":"Boyle P.A.; Yu L.; Leurgans S.E.; Wilson R.S.; Brookmeyer R.; Schneider J.A.; Bennett D.A.; Attributable risk of Alzheimer\u2019s dementia attributed to age\u2010related neuropathologies. Ann Neurol  2019,85(1),114-124","journal-title":"Ann Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","volume":"15","author":"Jahn H.","year":"2013","unstructured":"Jahn H.; Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosci  2013,15(4),445-454","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/13607863.2017.1408772","volume":"23","author":"Giebel C.M.","year":"2019","unstructured":"Giebel C.M.; Worden A.; Challis D.; Jolley D.; Bhui K.S.; Lambat A.; Kampanellou E.; Purandare N.; Age, memory loss and perceptions of dementia in south asian ethnic minorities. Aging Ment Health  2019,23(2),173-182","journal-title":"Aging Ment Health"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"695286","DOI":"10.3389\/fpsyt.2021.695286","volume":"12","author":"Ku\u0142ak-Bejda A.","year":"2021","unstructured":"Ku\u0142ak-Bejda A.; Bejda G.; Waszkiewicz N.; Mental disorders, cognitive impairment and the risk of suicide in older adults. Front Psychiatry  2021,12,695286","journal-title":"Front Psychiatry"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"Srivastava S.","year":"2021","unstructured":"Srivastava S.; Ahmad R.; Khare S.K.; Alzheimer\u2019s disease and its treatment by different approaches: A review. Eur J Med Chem  2021,216,113320","journal-title":"Eur J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/biomedicines9121910","volume":"9","author":"Garc\u00eda-Morales V.","year":"2021","unstructured":"Garc\u00eda-Morales V.; Gonz\u00e1lez-Acedo A.; Melguizo-Rodr\u00edguez L.; Pardo-Moreno T.; Costela-Ruiz V.J.; Montiel-Troya M.; Ramos-Rodr\u00edguez J.J.; Current understanding of the physiopathology, diagnosis and therapeutic approach to alzheimer\u2019s disease. Biomedicines  2021,9(12),1910","journal-title":"Biomedicines"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","volume":"8","author":"Porsteinsson A.P.","year":"2021","unstructured":"Porsteinsson A.P.; Isaacson R.S.; Knox S.; Sabbagh M.N.; Rubino I.; Diagnosis of early Alzheimer\u2019s disease: Clinical practice in 2021. J Prev Alzheimers Dis  2021,8(3),371-386","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3233\/JAD-215707","volume":"88","author":"Toups K.","year":"2022","unstructured":"Toups K.; Hathaway A.; Gordon D.; Chung H.; Raji C.; Boyd A.; Hill B.D.; Hausman-Cohen S.; Attarha M.; Chwa W.J.; Jarrett M.; Bredesen D.E.; Precision medicine approach to Alzheimer\u2019s disease: Successful pilot project. J Alzheimers Dis  2022,88(4),1411-1421","journal-title":"J Alzheimers Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/1568026619666190128125912","volume":"19","author":"Saxena M.","year":"2019","unstructured":"Saxena M.; Dubey R.; Target enzyme in Alzheimer\u2019s disease: Acetylcholinesterase inhibitors. Curr Top Med Chem  2019,19(4),264-275","journal-title":"Curr Top Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","volume":"31","author":"Bortolami M.","year":"2021","unstructured":"Bortolami M.; Rocco D.; Messore A.; Di Santo R.; Costi R.; Madia V.N.; Scipione L.; Pandolfi F.; Acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease \u2013 a patent review (2016\u2013present). Expert Opin Ther Pat  2021,31(5),399-420","journal-title":"Expert Opin Ther Pat"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"13578","DOI":"10.1039\/C9CP02613D","volume":"21","author":"Ghosh S.","year":"2019","unstructured":"Ghosh S.; Jana K.; Ganguly B.; Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer\u2019s disease by donepezil: A metadynamics simulation study. Phys Chem Chem Phys  2019,21(25),13578-13589","journal-title":"Phys Chem Chem Phys"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/ijms22031273","volume":"22","author":"Bekdash R.A.","year":"2021","unstructured":"Bekdash R.A.; The cholinergic system, the adrenergic system and the neuropathology of Alzheimer\u2019s disease. Int J Mol Sci  2021,22(3),1273","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1039\/D0CP03620J","volume":"23","author":"Schultz K.J.","year":"2021","unstructured":"Schultz K.J.; Colby S.M.; Yesiltepe Y.; Nu\u00f1ez J.R.; McGrady M.Y.; Renslow R.S.; Application and assessment of deep learning for the generation of potential NMDA receptor antagonists. Phys Chem Chem Phys  2021,23(2),1197-1214","journal-title":"Phys Chem Chem Phys"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.physbeh.2019.01.005","volume":"202","author":"Amani M.","year":"2019","unstructured":"Amani M.; Zolghadrnasab M.; Salari A.A.; NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease. Physiol Behav  2019,202,52-61","journal-title":"Physiol Behav"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","volume":"44","author":"Calvo-Rodriguez M.","year":"2021","unstructured":"Calvo-Rodriguez M.; Bacskai B.J.; Mitochondria and calcium in Alzheimer\u2019s disease: From cell signaling to neuronal cell death. Trends Neurosci  2021,44(2),136-151","journal-title":"Trends Neurosci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.31887\/DCNS.2000.2.3\/jnewcomer","volume":"2","author":"Newcomer J.W.","year":"2000","unstructured":"Newcomer J.W.; Farber N.B.; Olney J.W.; NMDA receptor function, memory, and brain aging. Dialogues Clin Neurosci  2000,2(3),219-232","journal-title":"Dialogues Clin Neurosci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1113\/JP280875","volume":"600","author":"Geoffroy C.","year":"2022","unstructured":"Geoffroy C.; Paoletti P.; Mony L.; Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential. J Physiol  2022,600(2),233-259","journal-title":"J Physiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"116974","DOI":"10.1016\/j.jns.2020.116974","volume":"416","author":"Uddin M.S.","year":"2020","unstructured":"Uddin M.S.; Kabir M.T.; Tewari D.; Mamun A.A.; Mathew B.; Aleya L.; Barreto G.E.; Bin-Jumah M.N.; Abdel-Daim M.M.; Ashraf G.M.; Revisiting the role of brain and peripheral A\u03b2 in the pathogenesis of Alzheimer\u2019s disease. J Neurol Sci  2020,416,116974","journal-title":"J Neurol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.25530","volume":"86","author":"Leonenko G.","year":"2019","unstructured":"Leonenko G.; Shoai M.; Bellou E.; Sims R.; Williams J.; Hardy J.; Escott-Price V.; Genetic risk for Alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol Alzheimer\u2019s Disease Neuroimaging Initiative 2019,86(3),427-435","journal-title":"Ann Neurol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.3390\/ijms22073654","volume":"22","author":"Soto-Rojas L.O.","year":"2021","unstructured":"Soto-Rojas L.O.; Campa-C\u00f3rdoba B.B.; Harrington C.R.; Salas-Casas A.; Hernandes-Alejandro M.; Villanueva-Fierro I.; Bravo-Mu\u00f1oz M.; Garc\u00e9s-Ram\u00edrez L.; De La Cruz-L\u00f3pez F.; Ontiveros-Torres M.\u00c1.; Gevorkian G.; Pacheco-Herrero M.; Luna-Mu\u00f1oz J.; Insoluble vascular amyloid deposits trigger disruption of the neurovascular unit in Alzheimer\u2019s disease brains. Int J Mol Sci  2021,22(7),3654","journal-title":"Int J Mol Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","volume":"95","author":"Kim J.W.","year":"2020","unstructured":"Kim J.W.; Byun M.S.; Lee J.H.; Yi D.; Jeon S.Y.; Sohn B.K.; Lee J.Y.; Shin S.A.; Kim Y.K.; Kang K.M.; Sohn C.H.; Lee D.Y.; Serum albumin and beta-amyloid deposition in the human brain. Neurology KBASE Research Group 2020,95(7),e815-e826","journal-title":"Neurology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jamaneurol.2019.0834","volume":"76","author":"Yu L.","year":"2019","unstructured":"Yu L.; Petyuk V.A.; Tasaki S.; Boyle P.A.; Gaiteri C.; Schneider J.A.; De Jager P.L.; Bennett D.A.; Association of cortical \u03b2-amyloid protein in the absence of insoluble deposits with Alzheimer disease. JAMA Neurol  2019,76(7),818-826","journal-title":"JAMA Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"Arnsten A.F.T.","year":"2021","unstructured":"Arnsten A.F.T.; Datta D.; Del Tredici K.; Braak H.; Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers Dement  2021,17(1),115-124","journal-title":"Alzheimers Dement"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","volume":"31","author":"Majdi A.","year":"2020","unstructured":"Majdi A.; Sadigh-Eteghad S.; Rahigh Aghsan S.; Farajdokht F.; Vatandoust S.M.; Namvaran A.; Mahmoudi J.; Amyloid-\u03b2, tau, and the cholinergic system in Alzheimer\u2019s disease: Seeking direction in a tangle of clues. Rev Neurosci  2020,31(4),391-413","journal-title":"Rev Neurosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1570159X18666200203101828","volume":"18","author":"Kumar D.","year":"2020","unstructured":"Kumar D.; Sharma A.; Sharma L.; A comprehensive review of Alzheimer\u2019s association with related proteins: Pathological role and therapeutic significance. Curr Neuropharmacol  2020,18(8),674-695","journal-title":"Curr Neuropharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.arr.2018.11.007","volume":"49","author":"Galv\u00e3o F.","year":"2019","unstructured":"Galv\u00e3o F.; Grokoski K.C.; da Silva B.B.; Lamers M.L.; Siqueira I.R.; The amyloid precursor protein (APP) processing as a biological link between Alzheimer\u2019s disease and cancer. Ageing Res Rev  2019,49,83-91","journal-title":"Ageing Res Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","volume":"7","author":"Tcw J.","year":"2017","unstructured":"Tcw J.; Goate A.M.; Genetics of \u03b2-amyloid precursor protein in Alzheimer\u2019s disease. Cold Spring Harb Perspect Med  2017,7(6),a024539","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","volume":"61","author":"Walsh D.M.","year":"2020","unstructured":"Walsh D.M.; Selkoe D.J.; Amyloid \u03b2-protein and beyond: The path forward in Alzheimer\u2019s disease. Curr Opin Neurobiol  2020,61,116-124","journal-title":"Curr Opin Neurobiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"Hampel H.","year":"2021","unstructured":"Hampel H.; Hardy J.; Blennow K.; Chen C.; Perry G.; Kim S.H.; Villemagne V.L.; Aisen P.; Vendruscolo M.; Iwatsubo T.; Masters C.L.; Cho M.; Lannfelt L.; Cummings J.L.; Vergallo A.; The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry  2021,26(10),5481-5503","journal-title":"Mol Psychiatry"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e0239584","DOI":"10.1371\/journal.pone.0239584","volume":"15","author":"Tackenberg C.","year":"2020","unstructured":"Tackenberg C.; Kulic L.; Nitsch R.M.; Familial Alzheimer\u2019s disease mutations at position 22 of the amyloid \u03b2-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. PLoS One  2020,15(9),e0239584","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1523\/JNEUROSCI.2501-19.2020","volume":"40","author":"Rolland M.","year":"2020","unstructured":"Rolland M.; Powell R.; Jacquier-Sarlin M.; Boisseau S.; Reynaud-Dulaurier R.; Martinez-Hernandez J.; Andr\u00e9 L.; Borel E.; Buisson A.; Lant\u00e9 F.; Effect of A\u03b2 oligomers on neuronal APP triggers a vicious cycle leading to the propagation of synaptic plasticity alterations to healthy neurons. J Neurosci  2020,40(27),5161-5176","journal-title":"J Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/1673-5374.313016","volume":"17","author":"Canales-Aguirre A.A.","year":"2022","unstructured":"Canales-Aguirre A.A.; Hernandez-Sapiens M.A.; Reza-Zald\u00edvar E.E.; M\u00e1rquez-Aguirre A.L.; G\u00f3mez-Pinedo U.; Matias-Guiu J.; Cevallos R.R.; Mateos-D\u00edaz J.C.; S\u00e1nchez-Gonz\u00e1lez V.J.; Presenilin mutations and their impact on neuronal differentiation in Alzheimer\u2019s disease. Neural Regen Res  2022,17(1),31-37","journal-title":"Neural Regen Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.18632\/aging.102677","volume":"12","author":"Gomez W.","year":"2020","unstructured":"Gomez W.; Morales R.; Maracaja-Coutinho V.; Parra V.; Nassif M.; Down syndrome and Alzheimer\u2019s disease: Common molecular traits beyond the amyloid precursor protein. Aging  2020,12(1),1011-1033","journal-title":"Aging"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e12057","DOI":"10.1002\/dad2.12057","volume":"12","author":"Henson R.L.","year":"2020","unstructured":"Henson R.L.; Doran E.; Christian B.T.; Handen B.L.; Klunk W.E.; Lai F.; Lee J.H.; Rosas H.D.; Schupf N.; Zaman S.H.; Lott I.T.; Fagan A.M.; Cerebrospinal fluid biomarkers of alzheimer\u2019s disease in a cohort of adults with down syndrome. Alzheimers Dement  2020,12(1),e12057","journal-title":"Alzheimers Dement"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"Lott I.T.","year":"2019","unstructured":"Lott I.T.; Head E.; Dementia in Down syndrome: Unique insights for Alzheimer disease research. Nat Rev Neurol  2019,15(3),135-147","journal-title":"Nat Rev Neurol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","volume":"32","author":"Pang K.","year":"2022","unstructured":"Pang K.; Jiang R.; Zhang W.; Yang Z.; Li L.L.; Shimozawa M.; Tambaro S.; Mayer J.; Zhang B.; Li M.; Wang J.; Liu H.; Yang A.; Chen X.; Liu J.; Winblad B.; Han H.; Jiang T.; Wang W.; Nilsson P.; Guo W.; Lu B.; An App knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments. Cell Res  2022,32(2),157-175","journal-title":"Cell Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"12246","DOI":"10.3390\/ijms241512246","volume":"24","author":"Volloch V","year":"2023","unstructured":"Volloch V; Rits-Volloch S; The amyloid cascade hypothesis 2.0 for Alzheimer's disease and aging-associated cognitive decline: From molecular basis to effective therapy. Int J Mol Sci  2023,24(15),12246-12246","journal-title":"Int J Mol Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainresbull.2016.04.007","volume":"126","author":"Ohno M.","year":"2016","unstructured":"Ohno M.; Alzheimer\u2019s therapy targeting the \u03b2-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies. Brain Res Bull  2016,126(Pt 2),183-198","journal-title":"Brain Res Bull"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cbi.2016.04.009","volume":"259","author":"Nalivaeva N.N.","year":"2016","unstructured":"Nalivaeva N.N.; Turner A.J.; AChE and the amyloid precursor protein (APP) \u2013 Cross-talk in Alzheimer\u2019s disease. Chem Biol Interact  2016,259(Pt B),301-306","journal-title":"Chem Biol Interact"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/2211-5463.13023","volume":"10","author":"Atali S.","year":"2020","unstructured":"Atali S.; Dorandish S.; Devos J.; Williams A.; Price D.; Taylor J.; Guthrie J.; Heyl D.; Evans H.G.; Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP. FEBS Open Bio  2020,10(12),2805-2823","journal-title":"FEBS Open Bio"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","volume":"7","author":"Lushchekina S.V.","year":"2017","unstructured":"Lushchekina S.V.; Kots E.D.; Novichkova D.A.; Petrov K.A.; Masson P.; Role of acetylcholinesterase in \u03b2-amyloid aggregation studied by accelerated molecular dynamics. Bionanoscience  2017,7(2),396-402","journal-title":"Bionanoscience"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2478\/cait-2020-0068","volume":"20","author":"Atanasova M.","year":"2020","unstructured":"Atanasova M.; Dimitrov I.; Ivanov S.; Molecular dynamics simulations of acetylcholinesterase-beta-amyloid peptide complex. Cybern Inf Technol  2020,20(6),140-154","journal-title":"Cybern Inf Technol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopha.2016.06.021","volume":"83","author":"Sohanaki H.","year":"2016","unstructured":"Sohanaki H.; Baluchnejadmojarad T.; Nikbakht F.; Roghani M.; Pelargonidin improves memory deficit in amyloid \u03b225-35 rat model of Alzheimer\u2019s disease by inhibition of glial activation, cholinesterase, and oxidative stress. Biomed Pharmacother  2016,83,85-91","journal-title":"Biomed Pharmacother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.01.091","volume":"174","author":"Zou X.","year":"2021","unstructured":"Zou X.; Xie R.; Li W.; Su C.; Chen Y.; Tang H.; Novel sampangine derivatives as potent inhibitors of Cu-mediated amyloid-\u03b2 protein aggregation, oxidative stress and inflammation. Int J Biol Macromol  2021,174,1-10","journal-title":"Int J Biol Macromol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2019.02.030","volume":"135","author":"Huang H.","year":"2019","unstructured":"Huang H.; Lou X.; Hu B.; Zhou Z.; Chen J.; Tian Y.; A comprehensive study on the generation of reactive oxygen species in Cu-A\u03b2-catalyzed redox processes. Free Radic Biol Med  2019,135,125-131","journal-title":"Free Radic Biol Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s12640-018-9975-2","volume":"35","author":"Sharma S.","year":"2019","unstructured":"Sharma S.; Sharma N.; Saini A.; Nehru B.; Carbenoxolone reverses the amyloid beta 1\u201342 oligomer\u2013induced oxidative damage and anxiety-related behavior in rats. Neurotox Res  2019,35(3),654-667","journal-title":"Neurotox Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"101283","DOI":"10.1016\/j.redox.2019.101283","volume":"26","author":"de Dios C.","year":"2019","unstructured":"de Dios C.; Bartolessis I.; Roca-Agujetas V.; Barbero-Camps E.; Mari M.; Morales A.; Colell A.; Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress. Redox Biol  2019,26,101283","journal-title":"Redox Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7698560","volume":"2020","author":"Li Y.","year":"2020","unstructured":"Li Y.; Lu J.; Cao X.; Zhao H.; Gao L.; Xia P.; Pei G.; A newly synthesized rhamnoside derivative alleviates Alzheimer\u2019s Amyloid-\u03b2-Induced oxidative stress, mitochondrial dysfunction, and cell senescence through upregulating SIRT3. Oxid Med Cell Longev  2020,2020,1-16","journal-title":"Oxid Med Cell Longev"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1021\/acs.jcim.8b00983","volume":"59","author":"Strodel B.","year":"2019","unstructured":"Strodel B.; Coskuner-Weber O.; Transition metal ion interactions with disordered amyloid-\u03b2 peptides in the pathogenesis of Alzheimer\u2019s disease: insights from computational chemistry studies. J Chem Inf Model  2019,59(5),1782-1805","journal-title":"J Chem Inf Model"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/ijms24021717","volume":"24","author":"Bubley A.","year":"2023","unstructured":"Bubley A.; Erofeev A.; Gorelkin P.; Beloglazkina E.; Majouga A.; Krasnovskaya O.; Tacrine-based hybrids: Past, present, and future. Int J Mol Sci  2023,24(2),1717","journal-title":"Int J Mol Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/10738584211016409","volume":"29","author":"Mota I.F.L.","year":"2023","unstructured":"Mota I.F.L.; de Lima L.S.; Santana B.M.; Gobbo G.A.M.; Bicca J.V.M.L.; Azevedo J.R.M.; Veras L.G.; Taveira R.A.A.; Pinheiro G.B.; Mortari M.R.; Alzheimer\u2019s disease: Innovative therapeutic approaches based on peptides and nanoparticles. Neuroscientist  2023,29(1),78-96","journal-title":"Neuroscientist"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"7252882","DOI":"10.1155\/2022\/7252882","volume":"2022","author":"Mitra S.","year":"2022","unstructured":"Mitra S.; Muni M.; Shawon N.J.; Das R.; Emran T.B.; Sharma R.; Chandran D.; Islam F.; Hossain M.J.; Safi S.Z.; Sweilam S.H.; Tacrine derivatives in neurological disorders: Focus on molecular mechanisms and neurotherapeutic potential. Oxid Med Cell Longev  2022,2022(1),7252882","journal-title":"Oxid Med Cell Longev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.tiv.2006.01.002","volume":"20","author":"Ezoulin M.J.M.","year":"2006","unstructured":"Ezoulin M.J.M.; Dong C.Z.; Liu Z.; Li J.; Chen H.Z.; Heymans F.; Leli\u00e8vre L.; Ombetta J.E.; Massicot F.; Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. Toxicol In Vitro  2006,20(6),824-831","journal-title":"Toxicol In Vitro"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/ph4020382","volume":"4","author":"Kozurkova M.","year":"2011","unstructured":"Kozurkova M.; Hamulakova S.; Gazova Z.; Paulikova H.; Kristian P.; Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties. Pharmaceuticals  2011,4(2),382-418","journal-title":"Pharmaceuticals"},{"key":"ref=63","year":"2012","unstructured":"LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD)  2012","journal-title":"Bethesda (MD)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1389557523666221201145141","volume":"23","author":"Yamali C.","year":"2023","unstructured":"Yamali C.; Donmez S.; Recent developments in tacrine-based hybrids as a therapeutic option for Alzheimer\u2019s disease. Mini Rev Med Chem  2023,23(7),869-880","journal-title":"Mini Rev Med Chem"},{"key":"ref=65","first-page":"538","volume":"82","author":"Cui S.","year":"2002","unstructured":"Cui S.; Wang M.; Fan G.; [Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study]. Zhonghua Yi Xue Za Zhi  2002,82(8),538-540","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejmech.2017.12.005","volume":"144","author":"Cen J.","year":"2018","unstructured":"Cen J.; Guo H.; Hong C.; Lv J.; Yang Y.; Wang T.; Fang D.; Luo W.; Wang C.; Development of tacrine-bifendate conjugates with improved cholinesterase inhibitory and pro-cognitive efficacy and reduced hepatotoxicity. Eur J Med Chem  2018,144,128-136","journal-title":"Eur J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s11064-022-03530-2","volume":"47","author":"Shukla M.","year":"2022","unstructured":"Shukla M.; Wongchitrat P.; Govitrapong P.; A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies\u2013Emphasis on Alzheimer\u2019s Disease Pathogenesis. Neurochem Res  2022,47(5),1166-1182","journal-title":"Neurochem Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0960-894X(99)00396-0","volume":"9","author":"Carlier P.R.","year":"1999","unstructured":"Carlier P.R.; Du D.M.; Han Y.; Liu J.; Pang Y.P.; Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors. Bioorg Med Chem Lett  1999,9(16),2335-2338","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/jnc.15379","volume":"158","author":"Mak S.","year":"2021","unstructured":"Mak S.; Li W.; Fu H.; Luo J.; Cui W.; Hu S.; Pang Y.; Carlier P.R.; Tsim K.W.; Pi R.; Han Y.; Promising tacrine\/huperzine A\u2010based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget. J Neurochem  2021,158(6),1381-1393","journal-title":"J Neurochem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/acschemneuro.1c00182","volume":"12","author":"Xuan Z.","year":"2021","unstructured":"Xuan Z.; Gu X.; Yan S.; Xie Y.; Zhou Y.; Zhang H.; Jin H.; Hu S.; Mak M.S.H.; Zhou D.; Keung Tsim K.W.; Carlier P.R.; Han Y.; Cui W.; Dimeric Tacrine (10)-hupyridone as a Multitarget-Directed ligand to treat Alzheimer\u2019s disease. ACS Chem Neurosci  2021,12(13),2462-2477","journal-title":"ACS Chem Neurosci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.transproceed.2014.01.018","volume":"46","author":"Yang Y","year":"2014","unstructured":"Yang Y; Yang J; Jiang Q; The protective effect of huperzine A against hepatic ischemia reperfusion injury in mice. Transplant Proc  2014,46(5),1573-1577","journal-title":"Transplant Proc"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcis.2020.03.075","volume":"573","author":"Arad E.","year":"2020","unstructured":"Arad E.; Green H.; Jelinek R.; Rapaport H.; Revisiting thioflavin T (ThT) fluorescence as a marker of protein fibrillation \u2013 The prominent role of electrostatic interactions. J Colloid Interface Sci  2020,573,87-95","journal-title":"J Colloid Interface Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1021\/acsmedchemlett.7b00294","volume":"8","author":"Kiritsis C.","year":"2017","unstructured":"Kiritsis C.; Mavroidi B.; Shegani A.; Palamaris L.; Loudos G.; Sagnou M.; Pirmettis I.; Papadopoulos M.; Pelecanou M.; 2-(4\u2032-Aminophenyl)benzothiazole labeled with tc-cyclopentadienyl for imaging \u03b2-amyloid plaques. ACS Med Chem Lett  2017,8(10),1089-1092","journal-title":"ACS Med Chem Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1039\/D0SC02641G","volume":"11","author":"Huang Y.","year":"2020","unstructured":"Huang Y.; Cho H.J.; Bandara N.; Sun L.; Tran D.; Rogers B.E.; Mirica L.M.; Metal-chelating benzothiazole multifunctional compounds for the modulation and  Cu PET imaging of A\u03b2 aggregation. Chem Sci (Camb)  2020,11(30),7789-7799","journal-title":"Chem Sci (Camb)"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/molecules24030587","volume":"24","author":"Rajeshwari R.","year":"2019","unstructured":"Rajeshwari R.; Chand K.; Candeias E.; Cardoso S.M.; Chaves S.; Santos M.A.; New multitarget hybrids bearing tacrine and phenylbenzothiazole motifs as potential drug candidates for alzheimer\u2019s disease. Molecules  2019,24(3),587","journal-title":"Molecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1038\/s41598-020-59451-z","volume":"10","author":"Chen J.","year":"2020","unstructured":"Chen J.; Yang J.; Ma L.; Li J.; Shahzad N.; Kim C.K.; Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Sci Rep  2020,10(1),2611","journal-title":"Sci Rep"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/nu14040819","volume":"14","author":"Caruso G.","year":"2022","unstructured":"Caruso G.; Godos J.; Privitera A.; Lanza G.; Castellano S.; Chillemi A.; Bruni O.; Ferri R.; Caraci F.; Grosso G.; Phenolic acids and prevention of cognitive decline: Polyphenols with a neuroprotective role in cognitive disorders and alzheimer\u2019s disease. Nutrients  2022,14(4),819","journal-title":"Nutrients"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fphar.2019.00509","volume":"10","author":"Saha P.","year":"2019","unstructured":"Saha P.; Talukdar A.D.; Nath R.; Sarker S.D.; Nahar L.; Sahu J.; Choudhury M.D.; Role of natural phenolics in hepatoprotection: a mechanistic review and analysis of regulatory network of associated genes. Front Pharmacol  2019,10,509","journal-title":"Front Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1021\/acschemneuro.0c00574","volume":"11","author":"Li K.","year":"2020","unstructured":"Li K.; Jiang Y.; Li G.; Liu T.; Yang Z.; Novel multitarget directed tacrine hybrids as anti-alzheimer\u2019s compounds improved synaptic plasticity and cognitive impairment in APP\/PS1 transgenic mice. ACS Chem Neurosci  2020,11(24),4316-4328","journal-title":"ACS Chem Neurosci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbi.2016.05.001","volume":"254","author":"de Souza L.G.","year":"2016","unstructured":"de Souza L.G.; Renn\u00f3 M.N.; Figueroa-Villar J.D.; Coumarins as cholinesterase inhibitors: A review. Chem Biol Interact  2016,254,11-23","journal-title":"Chem Biol Interact"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.3390\/cells10113095","volume":"10","author":"Huang C.C.","year":"2021","unstructured":"Huang C.C.; Chang K.H.; Chiu Y.J.; Chen Y.R.; Lung T.H.; Hsieh-Li H.M.; Su M.T.; Sun Y.C.; Chen C.M.; Lin W.; Lee-Chen G.J.; Multi-target effects of novel synthetic coumarin derivatives protecting a\u03b2-gfp sh-sy5y cells against a\u03b2 toxicity. Cells  2021,10(11),3095","journal-title":"Cells"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/molecules27072142","volume":"27","author":"Zeng F.","year":"2022","unstructured":"Zeng F.; Lu T.; Wang J.; Nie X.; Xiong W.; Yin Z.; Peng D.; Design, synthesis and bioactivity evaluation of coumarin\u2013BMT hybrids as new acetylcholinesterase inhibitors. Molecules  2022,27(7),2142","journal-title":"Molecules"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bioorg.2018.10.056","volume":"83","author":"Najafi Z.","year":"2019","unstructured":"Najafi Z.; Mahdavi M.; Saeedi M.; Karimpour-Razkenari E.; Edraki N.; Sharifzadeh M.; Khanavi M.; Akbarzadeh T.; Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer\u2019s compounds: In vitro and in vivo biological evaluation and docking study. Bioorg Chem  2019,83,303-316","journal-title":"Bioorg Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","volume":"4","author":"Carvajal F.J.","year":"2011","unstructured":"Carvajal F.J.; Inestrosa N.C.; Interactions of AChE with A\u03b2 aggregates in Alzheimer\u2019s brain: Therapeutic relevance of IDN 5706. Front Mol Neurosci  2011,4,19","journal-title":"Front Mol Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.bioorg.2019.103006","volume":"89","author":"Riazimontazer E.","year":"2019","unstructured":"Riazimontazer E.; Sadeghpour H.; Nadri H.; Sakhteman A.; T\u00fcyl\u00fc K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 T.; Miri R.; Edraki N.; Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem  2019,89,103006","journal-title":"Bioorg Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14715\/cmb\/2021.67.5.4","volume":"67","author":"Akhtar M.F.","year":"2022","unstructured":"Akhtar M.F.; Nisa M.; Saleem A.; Hamid I.; Alsharif K.F.; Abdel-Daim M.M.; Rahman M.H.; Shah M.; Sohail K.; Javaid Z.; Contemporary uses of old folks: The immunomodulatory and toxic potential of fenbufen. Cell Mol Biol  2022,67(5),27-37","journal-title":"Cell Mol Biol"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-230559\/v1","author":"Kaur S.","year":"2021","unstructured":"Kaur S.; Minhas R.; Kaur B.; Bansal Y.; Bansal G.; Design, synthesis and evaluation of benzimidazole-NsCOXis hybrids for the treatment of Alzheimer\u2019s disease. Research Square  2021","journal-title":"Research Square"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/07391102.2017.1338164","volume":"36","author":"Azam F.","year":"2018","unstructured":"Azam F.; Alabdullah N.H.; Ehmedat H.M.; Abulifa A.R.; Taban I.; Upadhyayula S.; NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer\u2019s disease: An investigation by docking, molecular dynamics, and DFT studies. J Biomol Struct Dyn  2018,36(8),2099-2117","journal-title":"J Biomol Struct Dyn"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"980818","DOI":"10.3389\/fvets.2022.980818","volume":"9","author":"Diez R.","year":"2022","unstructured":"Diez R.; Diez M.J.; Garcia J.J.; Rodriguez J.M.; Lopez C.; Fernandez N.; Sierra M.; Sahagun A.M.; Pharmacokinetics of menbutone after intravenous and intramuscular administration to sheep. Front Vet Sci  2022,9,980818","journal-title":"Front Vet Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"e2000083","DOI":"10.1002\/cbdv.202000083","volume":"18","author":"Hiremathad A.","year":"2021","unstructured":"Hiremathad A.; Chaves S.; Keri R.S.; Multi\u2010targeting tacrine conjugates with cholinesterase and amyloid\u2010beta inhibitory activities: New anti\u2010alzheimer\u2019s agents. Chem Biodivers  2021,18(2),e2000083","journal-title":"Chem Biodivers"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1021\/acs.jmedchem.7b00844","volume":"61","author":"Ha H.J.","year":"2018","unstructured":"Ha H.J.; Kang D.W.; Kim H.M.; Kang J.M.; Ann J.; Hyun H.J.; Lee J.H.; Kim S.H.; Kim H.; Choi K.; Hong H.S.; Kim Y.; Jo D.G.; Lee J.; Lee J.; Discovery of an orally bioavailable benzofuran analogue that serves as a \u03b2-amyloid aggregation inhibitor for the potential treatment of Alzheimer\u2019s disease. J Med Chem  2018,61(1),396-402","journal-title":"J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/cmdc.201800156","volume":"13","author":"Goyal D.","year":"2018","unstructured":"Goyal D.; Kaur A.; Goyal B.; Benzofuran and indole: Promising scaffolds for drug development in alzheimer\u2019s disease. ChemMedChem  2018,13(13),1275-1299","journal-title":"ChemMedChem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","volume":"59","author":"Zha X.","year":"2016","unstructured":"Zha X.; Lamba D.; Zhang L.; Lou Y.; Xu C.; Kang D.; Chen L.; Xu Y.; Zhang L.; De Simone A.; Samez S.; Pesaresi A.; Stojan J.; Lopez M.G.; Egea J.; Andrisano V.; Bartolini M.; Novel tacrine\u2013benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer\u2019s disease: Design, synthesis, biological evaluation, and X-ray crystallography. J Med Chem  2016,59(1),114-131","journal-title":"J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"133883","DOI":"10.1016\/j.molstruc.2022.133883","volume":"1270","author":"Yuldasheva N.","year":"2022","unstructured":"Yuldasheva N.; Acikyildiz N.; Akyuz M.; Yabo-Dambagi L.; Aydin T.; Cakir A.; Kazaz C.; The synthesis of schiff bases and new secondary amine derivatives of p-vanillin and evaluation of their neuroprotective, antidiabetic, antidepressant and antioxidant potentials. J Mol Struct  2022,1270,133883","journal-title":"J Mol Struct"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1039\/C9MD00048H","volume":"10","author":"Scipioni M.","year":"2019","unstructured":"Scipioni M.; Kay G.; Megson I.L.; Kong Thoo Lin P.; Synthesis of novel vanillin derivatives: Novel multi-targeted scaffold ligands against Alzheimer\u2019s disease. MedChemComm  2019,10(5),764-777","journal-title":"MedChemComm"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines9020099","volume":"9","author":"Devi S.","year":"2021","unstructured":"Devi S.; Kumar V.; Singh S.K.; Dubey A.K.; Kim J.J.; Flavonoids: Potential candidates for the treatment of neurodegenerative disorders. Biomedicines  2021,9(2),99","journal-title":"Biomedicines"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.eujim.2020.101272","volume":"43","author":"Meziant L.","year":"2021","unstructured":"Meziant L.; Bachir-bey M.; Bensouici C.; Saci F.; Boutiche M.; Louaileche H.; Assessment of inhibitory properties of flavonoid-rich fig (Ficus carica L.) peel extracts against tyrosinase, \u03b1-glucosidase, urease and cholinesterases enzymes, and relationship with antioxidant activity. Eur J Integr Med  2021,43,101272","journal-title":"Eur J Integr Med"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1021\/acs.jpcb.2c02763","volume":"126","author":"Alghamdi A.","year":"2022","unstructured":"Alghamdi A.; Birch D.J.S.; Vyshemirsky V.; Rolinski O.J.; Impact of the flavonoid quercetin on \u03b2-amyloid aggregation revealed by intrinsic fluorescence. J Phys Chem B  2022,126(38),7229-7237","journal-title":"J Phys Chem B"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejmech.2013.09.024","volume":"69","author":"Li S.Y.","year":"2013","unstructured":"Li S.Y.; Wang X.B.; Xie S.S.; Jiang N.; Wang K.D.G.; Yao H.Q.; Sun H.B.; Kong L.Y.; Multifunctional tacrine\u2013flavonoid hybrids with cholinergic, \u03b2-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer\u2019s disease. Eur J Med Chem  2013,69,632-646","journal-title":"Eur J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2174\/092986710791111206","volume":"17","author":"Tumiatti V.","year":"2010","unstructured":"Tumiatti V.; Minarini A.; Bolognesi M.L.; Milelli A.; Rosini M.; Melchiorre C.; Tacrine derivatives and alzheimer\u2019s disease. Curr Med Chem  2010,17(17),1825-1838","journal-title":"Curr Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bioorg.2019.02.033","volume":"86","author":"Ragab H.M.","year":"2019","unstructured":"Ragab H.M.; Teleb M.; Haidar H.R.; Gouda N.; Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer\u2019s disease. Bioorg Chem  2019,86,557-568","journal-title":"Bioorg Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1021\/jm900859q","volume":"52","author":"Camps P.","year":"2009","unstructured":"Camps P.; Formosa X.; Galdeano C.; Mu\u00f1oz-Torrero D.; Ram\u00edrez L.; G\u00f3mez E.; Isambert N.; Lavilla R.; Badia A.; Clos M.V.; Bartolini M.; Mancini F.; Andrisano V.; Arce M.P.; Rodr\u00edguez-Franco M.I.; Huertas \u00d3.; Dafni T.; Luque F.J.; Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and \u03b2-amyloid-directed anti-Alzheimer compounds. J Med Chem  2009,52(17),5365-5379","journal-title":"J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.3390\/molecules30173489","volume":"30","author":"Wang X.","year":"2025","unstructured":"Wang X.; Ma M.; Feng Y.; Liu J.; Wang G.; Multifunctional tacrine\u2013quinoline hybrids as cholinesterase inhibitors, A\u03b2 aggregation blockers, and metal chelators for alzheimer\u2019s therapy. Molecules  2025,30(17),3489","journal-title":"Molecules"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1474-9726.2012.00845.x","volume":"11","author":"Noristani H.N.","year":"2012","unstructured":"Noristani H.N.; Verkhratsky A.; Rodr\u00edguez J.J.; High tryptophan diet reduces CA1 intraneuronal \u03b2\u2010amyloid in the triple transgenic mouse model of Alzheimer\u2019s disease. Aging Cell  2012,11(5),810-822","journal-title":"Aging Cell"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trci.2018.10.005","volume":"4","author":"Tournissac M.","year":"2018","unstructured":"Tournissac M.; Vandal M.; Tremblay C.; Bourassa P.; Vancassel S.; Emond V.; Gangloff A.; Calon F.; Dietary intake of branched\u2010chain amino acids in a mouse model of Alzheimer\u2019s disease: Effects on survival, behavior, and neuropathology. Alzheimers Dement  2018,4(1),677-687","journal-title":"Alzheimers Dement"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/10408398.2017.1357534","volume":"59","author":"Ka\u0142u\u017cna-Czapli\u0144ska J.","year":"2019","unstructured":"Ka\u0142u\u017cna-Czapli\u0144ska J.; G\u0105tarek P.; Chirumbolo S.; Chartrand M.S.; Bj\u00f8rklund G.; How important is tryptophan in human health? Crit Rev Food Sci Nutr  2019,59(1),72-88","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","volume":"168","author":"Chalupova K.","year":"2019","unstructured":"Chalupova K.; Korabecny J.; Bartolini M.; Monti B.; Lamba D.; Caliandro R.; Pesaresi A.; Brazzolotto X.; Gastellier A.J.; Nachon F.; Pejchal J.; Jarosova M.; Hepnarova V.; Jun D.; Hrabinova M.; Dolezal R.; Zdarova Karasova J.; Mzik M.; Kristofikova Z.; Misik J.; Muckova L.; Jost P.; Soukup O.; Benkova M.; Setnicka V.; Habartova L.; Chvojkova M.; Kleteckova L.; Vales K.; Mezeiova E.; Uliassi E.; Valis M.; Nepovimova E.; Bolognesi M.L.; Kuca K.; Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer\u2019s disease. Eur J Med Chem  2019,168,491-514","journal-title":"Eur J Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1016\/j.bmc.2013.05.028","volume":"21","author":"Keri R.S.","year":"2013","unstructured":"Keri R.S.; Quintanova C.; Marques S.M.; Esteves A.R.; Cardoso S.M.; Santos M.A.; Design, synthesis and neuroprotective evaluation of novel tacrine\u2013benzothiazole hybrids as multi-targeted compounds against Alzheimer\u2019s disease. Bioorg Med Chem  2013,21(15),4559-4569","journal-title":"Bioorg Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1624677\/v1","author":"Kumar H.","year":"2022","unstructured":"Kumar H.; Goyal A.; Kumar N.; Garg P.; Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer\u2019s disease. Research Square  2022","journal-title":"Research Square"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"104596","DOI":"10.1016\/j.bioorg.2020.104596","volume":"107","author":"Nepovimova E.","year":"2021","unstructured":"Nepovimova E.; Svobodova L.; Dolezal R.; Hepnarova V.; Junova L.; Jun D.; Korabecny J.; Kucera T.; Gazova Z.; Motykova K.; Kubackova J.; Bednarikova Z.; Janockova J.; Jesus C.; Cortes L.; Pina J.; Rostohar D.; Serpa C.; Soukup O.; Aitken L.; Hughes R.E.; Musilek K.; Muckova L.; Jost P.; Chvojkova M.; Vales K.; Valis M.; Chrienova Z.; Chalupova K.; Kuca K.; Tacrine \u2013 benzothiazoles: Novel class of potential multitarget anti-alzheime\u0155s drugs dealing with cholinergic, amyloid and mitochondrial systems. Bioorg Chem  2021,107,104596","journal-title":"Bioorg Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3892\/etm.2019.8391","volume":"19","author":"Kosuge Y.","year":"2019","unstructured":"Kosuge Y.; Neuroprotective mechanisms of S-allyl-L-cysteine in neurological disease. Exp Ther Med  2019,19(2),1565-1569","journal-title":"Exp Ther Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-200067","volume":"75","author":"Andrade V.","year":"2020","unstructured":"Andrade V.; Cort\u00e9s N.; Pastor G.; Gonzalez A.; Ramos-Escobar N.; Pastene E.; Rojo L.E.; Maccioni R.B.; N-Acetyl cysteine and catechin-derived polyphenols: A path toward multi-target compounds against Alzheimer\u2019s disease. J Alzheimers Dis  2020,75(4),1219-1227","journal-title":"J Alzheimers Dis"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"126880","DOI":"10.1016\/j.bmcl.2019.126880","volume":"30","author":"do Carmo Carreiras M.","year":"2020","unstructured":"do Carmo Carreiras M.; Ismaili L.; Marco-Contelles J.; Propargylamine-derived multi-target directed ligands for alzheimer\u2019s disease therapy. Bioorg Med Chem Lett  2020,30(3),126880","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cbdd.12633","volume":"87","author":"Keri R.S.","year":"2016","unstructured":"Keri R.S.; Quintanova C.; Chaves S.; Silva D.F.; Cardoso S.M.; Santos M.A.; New tacrine hybrids with natural\u2010based cysteine derivatives as multitargeted drugs for potential treatment of alzheimer\u2019s disease. Chem Biol Drug Des  2016,87(1),101-111","journal-title":"Chem Biol Drug Des"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","volume":"32","author":"Lan J.S.","year":"2017","unstructured":"Lan J.S.; Hou J.W.; Liu Y.; Ding Y.; Zhang Y.; Li L.; Zhang T.; Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N -benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease. J Enzyme Inhib Med Chem  2017,32(1),776-788","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"103844","DOI":"10.1016\/j.bioorg.2020.103844","volume":"99","author":"Liao Q.","year":"2020","unstructured":"Liao Q.; Li Q.; Zhao Y.; Jiang P.; Yan Y.; Sun H.; Liu W.; Feng F.; Qu W.; Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer\u2019s disease. Bioorg Chem  2020,99,103844","journal-title":"Bioorg Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.3390\/molecules25204647","volume":"25","author":"Muronetz V.I.","year":"2020","unstructured":"Muronetz V.I.; Barinova K.; Kudryavtseva S.; Medvedeva M.; Melnikova A.; Sevostyanova I.; Semenyuk P.; Stroylova Y.; Sova M.; Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological transformation of amyloidogenic proteins. Molecules  2020,25(20),4647","journal-title":"Molecules"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1039\/C5MD00236B","volume":"6","author":"Quintanova C.","year":"2015","unstructured":"Quintanova C.; Keri R.S.; Marques S.M.; G-Fernandes M.; Cardoso S.M.; Lu\u00edsa Serralheiro M.; Am\u00e9lia Santos M.; Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs. MedChemComm  2015,6(11),1969-1977","journal-title":"MedChemComm"},{"key":"ref=119","author":"Xu Y.","year":"2016","unstructured":"Xu Y.; Fluorinated peptidomimetics: Synthesis, conformational studies and evaluation as amyloid proteins aggregation modulators. Doctor of Philosophy, Universit\u00e9 Paris-Saclay  2016","journal-title":"Doctor of Philosophy, Universit\u00e9 Paris-Saclay"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejmech.2016.03.077","volume":"116","author":"Zhang C.","year":"2016","unstructured":"Zhang C.; Du Q.Y.; Chen L.D.; Wu W.H.; Liao S.Y.; Yu L.H.; Liang X.T.; Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer\u2019s disease. Eur J Med Chem  2016,116,200-209","journal-title":"Eur J Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1002\/slct.201803672","volume":"4","author":"Girek M.","year":"2019","unstructured":"Girek M.; Szyma\u0144ski P.; Phyto\u2010tacrine hybrids as promising drugs to treat Alzheimer\u2019s disease. ChemistrySelect  2019,4(19),5776-5790","journal-title":"ChemistrySelect"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"876614","DOI":"10.3389\/fphar.2022.876614","volume":"13","author":"Piccialli I.","year":"2022","unstructured":"Piccialli I.; Tedeschi V.; Caputo L.; D\u2019Errico S.; Ciccone R.; De Feo V.; Secondo A.; Pannaccione A.; Exploring the therapeutic potential of phytochemicals in alzheimer\u2019s Disease: Focus on polyphenols and monoterpenes. Front Pharmacol  2022,13,876614","journal-title":"Front Pharmacol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","volume":"12","author":"Arbo B.D.","year":"2020","unstructured":"Arbo B.D.; Andr\u00e9-Miral C.; Nasre-Nasser R.G.; Schimith L.E.; Santos M.G.; Costa-Silva D.; Muccillo-Baisch A.L.; Hort M.A.; Resveratrol derivatives as potential treatments for Alzheimer\u2019s and Parkinson\u2019s disease. Front Aging Neurosci  2020,12,103","journal-title":"Front Aging Neurosci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmech.2016.12.048","volume":"127","author":"Je\u0159\u00e1bek J.","year":"2017","unstructured":"Je\u0159\u00e1bek J.; Uliassi E.; Guidotti L.; Kor\u00e1be\u010dn\u00fd J.; Soukup O.; Sepsova V.; Hrabinova M.; Ku\u010da K.; Bartolini M.; Pe\u00f1a-Altamira L.E.; Petralla S.; Monti B.; Roberti M.; Bolognesi M.L.; Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer\u2019s disease. Eur J Med Chem  2017,127,250-262","journal-title":"Eur J Med Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575422492251116190843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249178\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575422492251116190843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:09:32Z","timestamp":1779682172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249178\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575422492251116190843","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}